Skip to main content

Are you Dr. Zhang?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 5 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Jianzhong Zhang, MD is a board certified nuclear medicine physician in Hampton, Virginia. He is currently licensed to practice medicine in California.

Education & Training

  • Beijing Medical University
    Beijing Medical UniversityClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2025
  • American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

Publications & Presentations

Press Mentions

  • Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis
    Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque PsoriasisSeptember 24th, 2021
  • Helicobacterpylori Inhibits Autophagic Flux and Promotes Its Intracellular Survival and Colonization by down‐Regulating SIRT1
    Helicobacterpylori Inhibits Autophagic Flux and Promotes Its Intracellular Survival and Colonization by down‐Regulating SIRT1February 28th, 2021
  • Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic DermatitisOctober 26th, 2020
  • Join now to see all